JP2025502349A5 - - Google Patents
Info
- Publication number
- JP2025502349A5 JP2025502349A5 JP2024542255A JP2024542255A JP2025502349A5 JP 2025502349 A5 JP2025502349 A5 JP 2025502349A5 JP 2024542255 A JP2024542255 A JP 2024542255A JP 2024542255 A JP2024542255 A JP 2024542255A JP 2025502349 A5 JP2025502349 A5 JP 2025502349A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- igf
- polysorbate
- protein
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263300860P | 2022-01-19 | 2022-01-19 | |
| US63/300,860 | 2022-01-19 | ||
| PCT/EP2023/051110 WO2023139115A1 (en) | 2022-01-19 | 2023-01-18 | Compositions and methods for reducing oxidation of igf‐1/igfbp |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502349A JP2025502349A (ja) | 2025-01-24 |
| JP2025502349A5 true JP2025502349A5 (enExample) | 2026-01-26 |
Family
ID=85036292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024542255A Pending JP2025502349A (ja) | 2022-01-19 | 2023-01-18 | Ｉｇｆ－１／ｉｇｆｂｐの酸化を低減するための組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250099541A1 (enExample) |
| EP (1) | EP4466281A1 (enExample) |
| JP (1) | JP2025502349A (enExample) |
| KR (1) | KR20240136382A (enExample) |
| CN (1) | CN118574840A (enExample) |
| AU (1) | AU2023210427A1 (enExample) |
| CA (1) | CA3242513A1 (enExample) |
| IL (1) | IL314331A (enExample) |
| MX (1) | MX2024008819A (enExample) |
| WO (1) | WO2023139115A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3005966T3 (en) * | 2020-10-19 | 2025-03-17 | Oak Hill Bio Ltd | Compositions suitable for use in neonates |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL71991A (en) | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
| AU627423B2 (en) | 1987-04-06 | 1992-08-27 | Celtrix Pharmaceuticals, Inc. | Human somatomedin carrier protein subunits and process for producing them |
| DK131988A (da) | 1988-03-11 | 1989-09-12 | Erasmus University | Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur |
| US5258287A (en) | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
| DE3854842T2 (de) | 1988-04-12 | 1996-06-13 | Amgen Boulder Inc | Verfahren zur steigerung und zur hemmung der wirkung eines insulinähnlichen wachstumfaktors |
| GB8826451D0 (en) | 1988-11-11 | 1988-12-14 | Sandoz Ltd | Improvements in/relating to organic compounds |
| IL92816A0 (en) | 1988-12-22 | 1990-09-17 | Biogrowth Inc | Recombinant dna molecules,hosts,processes and human somatomedin carrier protein-like polypeptides |
| AU4238493A (en) | 1992-05-08 | 1993-12-13 | Thomas Jefferson University | IGF-1 analogs |
| US5563046A (en) | 1993-08-02 | 1996-10-08 | Celtrix Pharmaceuticals, Inc. | Fusion polypeptides and proteins |
| US5789547A (en) | 1995-06-07 | 1998-08-04 | Celtrix Pharmaceuticals, Inc. | Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding |
| US6121416A (en) | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
| US20110152188A1 (en) * | 2009-12-23 | 2011-06-23 | Hanns-Christian Mahler | Pharmaceutical compositions of igf/i proteins |
| ES3005966T3 (en) | 2020-10-19 | 2025-03-17 | Oak Hill Bio Ltd | Compositions suitable for use in neonates |
-
2023
- 2023-01-18 JP JP2024542255A patent/JP2025502349A/ja active Pending
- 2023-01-18 CA CA3242513A patent/CA3242513A1/en active Pending
- 2023-01-18 CN CN202380017851.4A patent/CN118574840A/zh active Pending
- 2023-01-18 AU AU2023210427A patent/AU2023210427A1/en active Pending
- 2023-01-18 US US18/730,442 patent/US20250099541A1/en active Pending
- 2023-01-18 IL IL314331A patent/IL314331A/en unknown
- 2023-01-18 KR KR1020247027032A patent/KR20240136382A/ko active Pending
- 2023-01-18 EP EP23701335.4A patent/EP4466281A1/en active Pending
- 2023-01-18 MX MX2024008819A patent/MX2024008819A/es unknown
- 2023-01-18 WO PCT/EP2023/051110 patent/WO2023139115A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6034054A (en) | Stable insulin formulations | |
| JP7202272B2 (ja) | インスリン分泌性ペプチドの安定な水性非経口医薬組成物 | |
| US5661125A (en) | Stable and preserved erythropoietin compositions | |
| JP5237522B2 (ja) | 改善された安定性を有する酸性インスリン調製物 | |
| TWI223597B (en) | Stable concentrated insulin preparations for pulmonary delivery | |
| JP5753692B2 (ja) | タンパク質製剤 | |
| WO2001064241A1 (en) | Preparations stabilized over long time | |
| WO2000051629A1 (en) | Preparations stabilized over long time | |
| CA2275890A1 (en) | Stable liquid interferon formulations | |
| JP2005526126A (ja) | インスリンアスパルト及びインスリンデテミアを含む可溶性製剤 | |
| JP2023550203A5 (enExample) | ||
| JPS6260370B2 (enExample) | ||
| FI4228676T3 (fi) | Koostumuksia, jotka sopivat vastasyntyneillä käytettäviksi | |
| EP1283051B1 (en) | Stable insulin formulations | |
| CN1264569C (zh) | 无蛋白制剂 | |
| WO2002017957A1 (en) | Solution preparations stabilized over long time | |
| WO2001041793A1 (fr) | Formulation stable d'interferon en solution, son procede de preparation et ses applications | |
| JPWO1999044630A1 (ja) | 蛋白非添加製剤 | |
| IL314331A (en) | Methods and compounds for reducing oxidation of IGF-1/IGFBP | |
| EA010626B1 (ru) | Жидкий состав гормона роста | |
| JP6445169B2 (ja) | α型インターフェロンを含有する安定したベンジルアルコールフリーの水溶液製剤 | |
| RU2024122721A (ru) | Композиции и способы для уменьшения окисления igf-1/igfbp | |
| JP2015224219A (ja) | 凍結乾燥製剤 | |
| JP4610154B2 (ja) | 注射用製剤 | |
| EP2585044B1 (en) | Long-term storage of non-glycosylated recombinant human g-csf |